Sinofn Health
Sinofn Health
In the competitive nutraceutical landscape, understanding the nuance between Ubiquinol and Ubiquinone is vital for brand differentiation. Coenzyme Q10 (CoQ10) is essential for cellular energy production. However, as consumers age, their natural ability to convert Ubiquinone (the oxidized form) into Ubiquinol (the reduced, active form) declines.
SINOFN Health specializes in advanced delivery systems that stabilize Ubiquinol, which is notoriously prone to oxidation, ensuring your product reaches the consumer with maximum potency. Our manufacturing process utilizes nitrogen-sealed encapsulation to protect the integrity of these volatile nutrients.
The "Made in China" label has evolved into "Engineered in China." SINOFN Health combines Tier-1 R&D capabilities with cost-effective, high-volume production. We provide:
SINOFN Health Co., Ltd. is the dedicated supplement OEM manufacturing division of SINOFN Group. Founded in 2012 and backed by the Chinese Academy of Sciences, we bridge the gap between complex pharmaceutical research and consumer-ready nutritional products.
Led by Dr. Tan Shengjie (Peking University) and Dr. Zhang Ying (CAS Postdoc), our R&D team ensures every formula is backed by clinical data rather than just market trends. Our Dutch consultant, Hans van Dijk, brings EU regulatory expertise to ensure your global expansion is seamless.
Q: What is the main difference between Ubiquinol and Ubiquinone for consumers?
A: Ubiquinol is the ready-to-use form that bypasses the body's conversion process, making it superior for the 40+ demographic, whereas Ubiquinone is cost-effective for younger populations.
Q: How does SINOFN ensure high quality in OEM manufacturing?
A: We utilize blockchain-based batch tracking, ISO 22000, HACCP, and FSSC 22000 certified processes to maintain full traceability from raw material to retail.
Q: Can you handle startups?
A: Yes. We offer pilot-scale prototyping, helping brands validate their CoQ10 formulations before mass production.
